Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Shares Outstanding (2016 - 2025)

Lexaria Bioscience's Shares Outstanding history spans 11 years, with the latest figure at $22.2 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 27.35% year-over-year to $22.2 million; the TTM value through Nov 2025 reached $22.2 million, up 27.35%, while the annual FY2025 figure was $19.6 million, 23.71% up from the prior year.
  • Shares Outstanding for Q4 2025 was $22.2 million at Lexaria Bioscience, up from $19.6 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $22.2 million in Q4 2025 and bottomed at $5.1 million in Q1 2021.
  • The 5-year median for Shares Outstanding is $8.1 million (2023), against an average of $11.2 million.
  • The largest annual shift saw Shares Outstanding changed 0.0% in 2023 before it soared 108.16% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $5.7 million in 2021, then grew by 3.92% to $6.0 million in 2022, then soared by 73.28% to $10.3 million in 2023, then soared by 69.25% to $17.5 million in 2024, then increased by 27.35% to $22.2 million in 2025.
  • Per Business Quant, the three most recent readings for LEXX's Shares Outstanding are $22.2 million (Q4 2025), $19.6 million (Q3 2025), and $19.6 million (Q2 2025).